Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366924 · ClinicalTrials.gov registry record · Phase 1
Essential Amino Acids Supplementation and Muscle Protein Synthesis
A Phase 1 study, sponsored by United States Army Research Institute of Environmental Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT01366924 is a Phase 1 study that has completed, run by United States Army Research Institute of Environmental Medicine. The registered enrollment target is 23 participants.
The verdict
NCT01366924, a Phase 1 study, has completed, sponsored by United States Army Research Institute of Environmental Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
The modern warfighter faces numerous physiological challenges including sleep deprivation, sustained intense physical activity, and caloric restriction, the combined effects of which may result in the loss of lean body mass and decreased physical performance. Dietary interventions may help preserve lean body mass and facilitate recovery from periods of intense physical demand. For example, dietary strategies that increase amino acid availability have been shown to stimulate protein synthesis in skeletal muscle following resistance exercise. Because military tasks also incorporate endurance exercise components, studies regarding the effects of increasing dietary amino acids following endurance exercise are warranted. The objectives of this study are to characterize the effect of endurance exercise on protein synthesis and breakdown as well as the ability of an essential amino acid supplement to influence skeletal muscle protein metabolism and its cellular and molecular regulation following endurance exercise.
Interventions
- DIETARY_SUPPLEMENT Essential Amino Acids
- OTHER Endurance exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-05 |
| Est. Completion | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01366924
The ClinicalTrials.gov registry entry for NCT01366924 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Research Institute of Environmental Medicine, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Essential Amino Acids is the first listed.
NCT01366924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01366924 about?
NCT01366924 is a clinical study titled "Essential Amino Acids Supplementation and Muscle Protein Synthesis". The modern warfighter faces numerous physiological challenges including sleep deprivation, sustained intense physical activity, and caloric restriction, the combined effects of which may result in the loss of lean body mass and decreased physical performance. Dietary interventions may help preserve ...
What is the current status of trial NCT01366924?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2007-05. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01366924?
The interventions under investigation include: Essential Amino Acids (DIETARY_SUPPLEMENT), Endurance exercise (OTHER).
Who is sponsoring clinical trial NCT01366924?
This trial is sponsored by United States Army Research Institute of Environmental Medicine, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.